Connect Sign In
0056060
Prothrombin ( F2 ) c.*97G>A (G20210A) Pathogenic Variant
PT PCR
Ordering Recommendation
Order to detect prothrombin c.*97G>A (G20210A) pathogenic variant.
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Collect
Lavender (EDTA), pink (K2EDTA), or yellow (ACD solution A or B).
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL)
Storage/Transport Temperature
Preferred transport temp: Refrigerated.
Unacceptable Conditions
Plasma or serum; collection of specimen in sodium heparin tubes. Frozen specimens in glass collection tubes.
Remarks
Counseling and informed consent are recommended for genetic testing. Consent forms are linked above.
New York Clients: informed consent is required with submission.
Stability
Room Temperature: 3 days; Refrigerated: 1 week; Frozen: 1 month
Methodology
Polymerase Chain Reaction (PCR) / Fluorescence Monitoring
Performed
Sun-Sat
Reported
2-5 days
Reference Interval
Interpretive Data
Refer to report.
Compliance Category
Laboratory Developed Test (LDT)
Note
Hotline History
N/A
CPT Codes
81240
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0056060 | Prothrombin (F2) G20210A Variant | 24475-6 |
| 2001334 | PT PCR Specimen | 31208-2 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- F2 DNA assay
- Factor II (PT) 20210 Variant
- Prothrombin Gene Analysis
Prothrombin (F2) c.*97G>A (G20210A) Pathogenic Variant
